Coronavirus disease-19 vaccine development utilizing promising technology
Authors:
- 1 November 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in HIV and AIDS
- Vol. 15 (6) , 351-358
Abstract
Purpose of review Coronavirus disease-19 (COVID-19) is a highly transmittable and pathogenic pneumonia-causing disease, which is caused by severe acute respiratory syndrome coronavirus-2, resulting in millions of deaths globally. Severe acute respiratory syndrome coronavirus-2 may coexist with human populations for a long time. Therefore, high-effective COVID-19 vaccines are an urgent need. Recent findings Vaccines help in the development of long-lasting humoral or cellular immunity, or both, by exposing individuals to antigens that induce an immunological response and memory prior to infections with live pathogens. New vaccine technologies, such as viral vectors and nucleic acid-based vaccines, which represent highly versatile technologies, may allow for faster vaccine manufacture and scale up production. We summarized the recent progress made in relation to COVID-19 vaccine development using several promising technologies, with particular emphasis on advancements that are currently at the clinical trial stage.Keywords
This publication has 25 references indexed in Scilit:
- Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against RabiesVaccines, 2019
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-CoronavirusFrontiers in Microbiology, 2019
- New Vaccine Technologies to Combat Outbreak SituationsFrontiers in Immunology, 2018
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Understanding modern-day vaccines: what you need to knowAnnals of Medicine, 2017
- Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast laneExpert Review of Vaccines, 2017
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicityHuman Vaccines & Immunotherapeutics, 2017
- Vaccine technologies: From whole organisms to rationally designed protein assembliesBiochemical Pharmacology, 2016
- Defending against smallpox: a focus on vaccinesExpert Review of Vaccines, 2016
- Rationalizing the development of live attenuated virus vaccinesNature Biotechnology, 2010